全文获取类型
收费全文 | 454044篇 |
免费 | 39852篇 |
国内免费 | 16128篇 |
专业分类
耳鼻咽喉 | 3215篇 |
儿科学 | 9310篇 |
妇产科学 | 6373篇 |
基础医学 | 75595篇 |
口腔科学 | 7893篇 |
临床医学 | 31566篇 |
内科学 | 76883篇 |
皮肤病学 | 7674篇 |
神经病学 | 37815篇 |
特种医学 | 9288篇 |
外国民族医学 | 124篇 |
外科学 | 34218篇 |
综合类 | 58832篇 |
现状与发展 | 59篇 |
一般理论 | 6篇 |
预防医学 | 21875篇 |
眼科学 | 5295篇 |
药学 | 64533篇 |
84篇 | |
中国医学 | 18417篇 |
肿瘤学 | 40969篇 |
出版年
2023年 | 6665篇 |
2022年 | 8786篇 |
2021年 | 17418篇 |
2020年 | 15585篇 |
2019年 | 16292篇 |
2018年 | 15753篇 |
2017年 | 15377篇 |
2016年 | 15131篇 |
2015年 | 17621篇 |
2014年 | 26486篇 |
2013年 | 30423篇 |
2012年 | 26634篇 |
2011年 | 30766篇 |
2010年 | 25762篇 |
2009年 | 25330篇 |
2008年 | 24667篇 |
2007年 | 22592篇 |
2006年 | 20272篇 |
2005年 | 17422篇 |
2004年 | 15069篇 |
2003年 | 13126篇 |
2002年 | 10548篇 |
2001年 | 9003篇 |
2000年 | 7552篇 |
1999年 | 6613篇 |
1998年 | 5391篇 |
1997年 | 5123篇 |
1996年 | 4472篇 |
1995年 | 4445篇 |
1994年 | 4046篇 |
1993年 | 3484篇 |
1992年 | 2920篇 |
1991年 | 2687篇 |
1990年 | 2244篇 |
1989年 | 1878篇 |
1988年 | 1710篇 |
1987年 | 1420篇 |
1986年 | 1382篇 |
1985年 | 3302篇 |
1984年 | 4125篇 |
1983年 | 2838篇 |
1982年 | 3091篇 |
1981年 | 2795篇 |
1980年 | 2271篇 |
1979年 | 1952篇 |
1978年 | 1565篇 |
1977年 | 1304篇 |
1976年 | 1404篇 |
1975年 | 1017篇 |
1973年 | 802篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
11.
12.
13.
14.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(1):151-159
Background & aimsTo determine the trends of self-reported non-adherence rates among adults taking Type 2 medicines (T2D) medicines between 2017 and 2019 and to identify the patterns for the frequently reported reasons for non-adherence in the United States.Methods & resultsData from the National Health and Wellness Survey, a self-administered, internet-based cross-sectional survey of US adults from 2017 to 2019 was used. Non-adherence was measured using the self-reported Medication Adherence Reasons Scale (MAR-Scale). Frequencies were used to identify the reasons for non-adherence for insulin and non-insulin therapies for T2D.Data were obtained from 2983 respondents in 2017, 5416 in 2018, and 5268 in 2019. Based on the MAR-Scale, the self-reported medication non-adherence rate was 25% in 2017, 21% in 2018, and 27% in 2019. The most common reason for non-adherence across all the three years was simple forgetfulness, yet patients reported the lowest mean number of days missing medication for that reason. Though less frequently reported, non-adherence lasted longer when patient did not know how to take their medicines, cost was a reason, or had concerns about the long term effects of the medicines.ConclusionsWith no significant improvement in adherence with T2D medicines over time, regardless of better awareness and extensive diabetes education, focus should be on individualized non-adherence reasons-based interventions. 相似文献
15.
16.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(7):1742-1752
Background and aimTo evaluate the effectiveness of structured exercise appropriate the circadian rhythm in terms of blood sample test (BST), functionality and quality of life (QoL) in individuals with type 2 diabetes.Methods and resultsThis was a parallel-group, single-blind, crossover study. Thirty individuals with type 2 diabetes aged 35–65 years were enrolled in the study and allocated into 2 groups as the Morning Chronotype (MC) Group (n = 15) and the Evening Chronotype (EC) Group (n = 15) using Morningness-Eveningness Questionnaire which was used to determine the chronotypes. Participants were evaluated in terms of BST, functionality and QoL at the beginning of the study (T0), at 6 (T1), 12 (T2), and 18 (T3) weeks after the study started. A structured exercise program for 3 days a week over 6 weeks was applied in accordance with the chronotypes (T1-T2) and cross-controlled for the chronotypes (T2-T3). Significant differences were found in favor of the exercise given at the appropriate time for the chronotype in all parameters in both groups within groups (T0-T1-T2-T3) (p < 0.05). In the time1group interactions, exercise in accordance with the appropriate chronotype in both groups provided the highest statistical improvement in all parameters (p < 0.05).ConclusionIt was concluded that structured exercise performed at the appropriate time for chronotype improves HbA1c, fasting blood glucose, HDL-LDL cholesterol, triglyceride, total cholesterol, functionality and quality of life in type 2 diabetes. This variation in blood values was observed to reflect the quantitative effects of exercise administered according to the circadian rhythm in individuals with type 2 diabetes.Trial registrationClinicalTrials.gov (NCT04427488). The protocol of the study was registered at ClinicalTrials.gov (NCT04427488). 相似文献
17.
目的研究异牡荆素(ISO)对非小细胞性肺癌(NSCLC)细胞的影响和潜在的机制。方法将A549和H1650细胞分别分为空白组、低剂量实验组(4μmol·L-1 ISO)和高剂量实验组(16μmol·L-1 ISO)。用噻唑蓝法检测NSCLC细胞活性,用肿瘤球形成实验检测NSCLC细胞的细胞球形成率,用Western blot法检测NSCLC细胞凋亡、自我更新、无翅型MMTV整合位点家族/β-连环蛋白(Wnt/β-catenin)信号通路相关蛋白的表达水平。结果与空白组比较,低、高剂量实验组中A549和H1650细胞在24,48和72 h的细胞活性均显著降低。低、高剂量实验组和空白组中A549细胞的细胞球形成率分别为(4.18±0.45)%,(2.01±0.67)%和(6.02±0.57)%,切割的半胱氨酸蛋白酶-3相对表达量分别为0.24±0.08,1.25±0.13和0.06±0.07,SRY相关高迁移率族盒蛋白-2相对表达量分别为0.49±0.04,0.25±0.03和1.00±0.09,Kruppel样因子4相对表达量分别为0.68±0.04,0.44±0.03和1.01±0.06,Wnt1相对表达量分别为0.63±0.06,0.28±0.04和1.00±0.06,β-catenin相对表达量分别为0.41±0.05,0.22±0.03和1.01±0.09;与空白组比较,低、高剂量实验组中A549细胞的上述指标的差异均有统计学意义(P<0.05,P<0.01)。上述3组中H1650细胞的上述指标也呈现一致的现象。结论ISO可能通过抑制Wnt/β-catenin信号通路来抑制NSCLC细胞活性和自我更新,并促进其凋亡。 相似文献
18.
Mixed lineage leukemia 1(MLL1)是组蛋白甲基转移酶SET家族的成员之一。MLL1与WDR5、RbBP5、Ash2L和DPY-30组成MLL1甲基转移酶复合物调控组蛋白H3的第4位赖氨酸的甲基化水平,对造血系统的发育和血细胞的更新至关重要。部分白血病患者体内存在因MLL1基因易位而产生的致癌蛋白——MLL1融合蛋白,MLL1融合蛋白在发挥其致癌作用时需要功能完整的MLL1酶复合物,故靶向MLL1-WDR5的蛋白-蛋白相互作用成为治疗MLL1融合型白血病的潜在策略。本文对MLL1-WDR5蛋白-蛋白相互作用的生物学机制、结构信息以及抑制剂进行了系统的总结,并结合已报道数据对该领域进行了展望,以期为后续研究提供参考。 相似文献
19.
《The Journal for Nurse Practitioners》2022,18(2):245-247
Transient stress hyperglycemia in the setting of acute myocardial infarction is a frequent phenomenon. Its transient nature should not dissuade the clinician from management of elevated blood glucose in a patient after an ST-elevation myocardial infarction. This case presents an adult patient after an ST-elevation myocardial infarction with transient stress hyperglycemia and the evidence used to identify optimal pharmacologic management and secondary prevention. 相似文献
20.